Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 CAD | 0.00% | +14.29% | +14.29% |
Apr. 02 | Appili Therapeutics To be Acquired by Aditxt, Inc. | MT |
Apr. 02 | Adivir, Inc. entered into a definitive agreement to acquire Appili Therapeutics Inc. for $6.7 million. | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.85M 3.55M |
---|---|---|---|---|---|
Net income 2024 * | -6M -4.39M | Net income 2025 * | -10M -7.32M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.74
x | P/E ratio 2025 * |
-0.74
x | Employees | 9 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.94% |
1 week | +14.29% | ||
Current month | +14.29% | ||
1 month | +33.33% | ||
3 months | +33.33% | ||
Current year | +14.29% |
Managers | Title | Age | Since |
---|---|---|---|
Don Cilla
CEO | Chief Executive Officer | 63 | 20-10-31 |
Armand Balboni
CHM | Chairman | 57 | 18-09-30 |
Kenneth Howling
DFI | Director of Finance/CFO | 66 | 21-11-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 20-01-26 | |
Prakash Gowd
BRD | Director/Board Member | 60 | Nov. 12 |
Director/Board Member | 70 | 21-02-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.04 | 0.00% | 5,140 |
24-04-22 | 0.04 | 0.00% | 31,819 |
24-04-19 | 0.04 | +14.29% | 99,000 |
24-04-18 | 0.035 | 0.00% | 5,000 |
24-04-17 | 0.035 | -12.50% | 331,000 |
Delayed Quote Toronto S.E., April 24, 2024 at 03:05 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.29% | 3.53M | |
-2.26% | 104B | |
+1.41% | 97.42B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.63% | 15.06B | |
+4.55% | 13.98B | |
+32.11% | 11.66B |
- Stock Market
- Equities
- APLI Stock